These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 26017300)
21. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity. Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132 [TBL] [Abstract][Full Text] [Related]
22. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems. Delgado A; Lavelle EC; Hartshorne M; Davis SS Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065 [TBL] [Abstract][Full Text] [Related]
23. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants. Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098 [TBL] [Abstract][Full Text] [Related]
24. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery. Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572 [TBL] [Abstract][Full Text] [Related]
25. Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses. Liu Q; Jia J; Yang T; Fan Q; Wang L; Ma G Small; 2016 Apr; 12(13):1744-57. PubMed ID: 26849717 [TBL] [Abstract][Full Text] [Related]
26. The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant. Jain S; O'Hagan DT; Singh M Expert Rev Vaccines; 2011 Dec; 10(12):1731-42. PubMed ID: 22085176 [TBL] [Abstract][Full Text] [Related]
27. Topical imiquimod is a potent adjuvant to a weakly-immunogenic protein prototype vaccine. Johnston D; Bystryn JC Vaccine; 2006 Mar; 24(11):1958-65. PubMed ID: 16310898 [TBL] [Abstract][Full Text] [Related]
28. Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus. Kingstad-Bakke B; Toy R; Lee W; Pradhan P; Vogel G; Marinaik CB; Larsen A; Gates D; Luu T; Pandey B; Kawaoka Y; Roy K; Suresh M Front Immunol; 2020; 11():559382. PubMed ID: 33767689 [TBL] [Abstract][Full Text] [Related]
29. A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles. Zhang XQ; Dahle CE; Weiner GJ; Salem AK J Pharm Sci; 2007 Dec; 96(12):3283-92. PubMed ID: 17497736 [TBL] [Abstract][Full Text] [Related]
30. Glucan Particles Are a Powerful Adjuvant for the HBsAg, Favoring Antiviral Immunity. Soares E; Groothuismink ZMA; Boonstra A; Borges O Mol Pharm; 2019 May; 16(5):1971-1981. PubMed ID: 30964694 [TBL] [Abstract][Full Text] [Related]
31. Characterization of protein-adjuvant coencapsulation in microparticles for vaccine delivery. Mathew S; Lendlein A; Wischke C Eur J Pharm Biopharm; 2014 Jul; 87(2):403-7. PubMed ID: 24747810 [TBL] [Abstract][Full Text] [Related]
32. The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant. Zhang Y; Gu P; Wusiman A; Xu S; Ni H; Qiu T; Liu Z; Hu Y; Liu J; Wang D Int J Nanomedicine; 2020; 15():5527-5543. PubMed ID: 32848386 [TBL] [Abstract][Full Text] [Related]
33. Antigen delivery by lipid-enveloped PLGA microparticle vaccines mediated by in situ vesicle shedding. Hanson MC; Bershteyn A; Crespo MP; Irvine DJ Biomacromolecules; 2014 Jul; 15(7):2475-81. PubMed ID: 24894061 [TBL] [Abstract][Full Text] [Related]
34. Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66. Carcaboso AM; Hernández RM; Igartua M; Gascón AR; Rosas JE; Patarroyo ME; Pedraz JL Int J Pharm; 2003 Jul; 260(2):273-82. PubMed ID: 12842346 [TBL] [Abstract][Full Text] [Related]